Targets Calcium/Calmodulin-Dependent Protein Kinase I (CaMKIl), a
key driver of drug-associated memory and relapse, aiming to disrupt
the addiction cycle and prevent long-term dependency.
Targets the Dopamine D3 Receptor (D3R), a central player of craving
and compulsive drug use, aiming to disrupt the brain's reward loop
that fuels addiction.
